Search results for "Kiev"

showing 10 items of 44 documents

Blanche de Castille

2009

[SHS.DROIT]Humanities and Social Sciences/Law[SHS.DROIT] Humanities and Social Sciences/Lawmonarchieduchesse de BerryrégentesBlanche de CastilleAnne de Kiev[ SHS.DROIT ] Humanities and Social Sciences/Lawfemmes de pouvoir
researchProduct

Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism

2003

Specific virus-receptor interactions are important determinants in the pathogenesis of viral infections, influencing the location and initiation of primary infection as well as the viral spread to other target organs in the postviremic phase. Coxsackieviruses of group B (CVB) specifically interact with at least two receptor proteins, the coxsackievirus-adenovirus receptor (CAR) and the decay-accelerating factor (DAF), and cause a broad spectrum of diseases, including acute and chronic myocarditis. In the human heart, CAR is predominantly expressed in intercalated discs, regions of utmost importance for the functional integrity of the heart. Since DAF is abundantly expressed in epithelial an…

Microbiology (medical)Coxsackie and Adenovirus Receptor-Like Membrane ProteinvirusesImmunologyCoxsackievirusmedicine.disease_causeVirusViral entryEnterovirus InfectionsmedicineHumansImmunology and AllergyReceptorDecay-accelerating factorCD55 AntigensbiologyMyocardiumVirus receptorGeneral Medicinebiology.organism_classificationVirologyEnterovirus B HumanAdenoviridaeMyocarditisReceptors VirusEnterovirusHeLa CellsMedical Microbiology and Immunology
researchProduct

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine

2020

Coxsackievirus B (CVB) enteroviruses are common pathogens that can cause acute and chronic myocarditis, dilated cardiomyopathy, aseptic meningitis, and they are hypothesized to be a causal factor in type 1 diabetes. The licensed enterovirus vaccines and those currently in clinical development are traditional inactivated or live attenuated vaccines. Even though these vaccines work well in the prevention of enterovirus diseases, new vaccine technologies, like virus-like particles (VLPs), can offer important advantages in the manufacturing and epitope engineering. We have previously produced VLPs for CVB3 and CVB1 in insect cells. Here, we describe the production of CVB3-VLPs with enhanced pro…

and promotion of well-beingvirusesPROTECTS MICEPOLIOVIRUSCardiovascularcomplex mixturesvirus-like particle (VLP)virus-like particleVaccine RelatedvaccineIMMUNE-RESPONSECoxsackievirus B (CVB)COXSACKIEVIRUS B3lcsh:QH301-705.5PARTICLE VACCINE11832 Microbiology and virologyPreventionrokotteetvirus diseasesMICROSCOPYPrevention of disease and conditionsenteroviruksetHeart DiseaseInfectious DiseasesGood Health and Well Beinglcsh:Biology (General)3.4 VaccinesCoxsackievirus BENTEROVIRUS 71VIRUSImmunization3111 BiomedicineInfectionRECEPTOR-BINDINGB1Biotechnology
researchProduct

Early entry events in Echovirus 30 infection

2020

Echovirus 30 (E30), a member of the enterovirus B species, is a major cause of viral meningitis, targeting children and adults alike. While it is a frequently isolated enterovirus and the cause of several outbreaks all over the world, surprisingly little is known regarding its entry and replication strategy within cells. In this study, we used E30 strain Bastianni (E30B) generated from an infectious cDNA clone in order to study early entry events during infection in human RD cells. E30B required the newly discovered Fc echovirus receptor (FcRn) for successful infection, but not the coxsackievirus and adenovirus receptor (CAR) or decay-accelerating factor (DAF), although an interaction with …

EchovirusvirusesReceptors FcVirus Replicationmedicine.disease_causeDisease OutbreaksPhylogenyEnterovirus0303 health sciencesbiologyenterovirusechovirusEnterovirus B HumanVirus-Cell InteractionsenteroviruksetCapsidaivokalvotulehdusRNA ViralECHO-viruksetEndosomeImmunologyEchovirus InfectionsCHO CellsCoxsackievirusMicrobiologyClathrininfektiotVirusCell Line03 medical and health sciencesCricetulusVirologyEnterovirus InfectionsViral meningitismedicineAnimalsHumans030304 developmental biologyearly entry030306 microbiologySequence Analysis DNAVirus Internalizationmedicine.diseasebiology.organism_classificationVirologyaseptic meningitisA549 CellsInsect Sciencebiology.proteinEnterovirus
researchProduct

Hydrophobic pocket targeting probes for enteroviruses

2015

Visualization and tracking of viruses without compromising their functionality is crucial in order to understand virus targeting to cells and tissues, and to understand the subsequent subcellular steps leading to virus uncoating and replication. Enteroviruses are important human pathogens causing a vast number of acute infections, and are also suggested to contribute to the development of chronic diseases like type I diabetes. Here, we demonstrate a novel method to target site-specifically the hydrophobic pocket of enteroviruses. A probe, a derivative of Pleconaril, was developed and conjugated to various labels that enabled the visualization of enteroviruses under light and electron micros…

EchovirusEndosomevirusesCoxsackievirus InfectionsBiologyCoxsackievirusmedicine.disease_causeenterovirusesVirusCell Line TumormedicineHumansGeneral Materials Sciencemolecular probesta116OxazolesFluorescent DyesInfectivityOxadiazolesVirus Uncoatingta1182trackingbiology.organism_classificationMolecular biologyEnterovirus B HumanCapsidhydrophobic pocketCytoplasmBiophysicsGoldHydrophobic and Hydrophilic InteractionsNanoscale
researchProduct

A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine

2019

Type B Coxsackieviruses (CVBs) belong to the enterovirus genus, and they cause both acute and chronic diseases in humans. CVB infections usually lead to flu-like symptoms but can also result in more serious diseases such as myocarditis, aseptic meningitis and life-threatening multi-organ infections in young infants. Thus, CVBs have long been considered as important targets of future vaccines. We have previously observed CVB1 capsid disintegration and virus concentration decrease with 12-day long formalin inactivation protocol. Here a scalable ion exchange chromatography purification method was developed, and purified CVB1 was inactivated with UV-C or formalin. Virus morphology and concentra…

enteroviruksetcoxsackievirus BBiolääketieteet - Biomedicinerokotteetultraviolettisäteilyinactivated vaccineformaldehydiformalinUV
researchProduct

2019

Abstract Type B Coxsackieviruses (CVBs) belong to the enterovirus genus, and they cause both acute and chronic diseases in humans. CVB infections usually lead to flu-like symptoms but can also result in more serious diseases such as myocarditis, aseptic meningitis and life-threatening multi-organ infections in young infants. Thus, CVBs have long been considered as important targets of future vaccines. We have previously observed CVB1 capsid disintegration and virus concentration decrease with 12-day long formalin inactivation protocol. Here a scalable ion exchange chromatography purification method was developed, and purified CVB1 was inactivated with UV-C or formalin. Virus morphology and …

General VeterinaryGeneral Immunology and MicrobiologybiologyChemistryImmunogenicity030231 tropical medicinePublic Health Environmental and Occupational HealthCoxsackievirusbiology.organism_classificationVirologyNeutralizationVirus3. Good health03 medical and health sciences0302 clinical medicineInfectious DiseasesAntigenVirus morphologyInactivated vaccinebiology.proteinMolecular Medicine030212 general & internal medicineNeutralizing antibodyVaccine
researchProduct

2019

Abstract Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like particles (VLPs) for CVB3 with a baculovirus-insect cell production system. Here we have explored the potential of a VLP-based vaccine targeting CVB1 and describe the production of CVB1-VLPs with a scalable VLP purification method. The developed purification method consisting of tangential flow filtration and ion exchange chromatography is compatible with industrial scale production. CVB1-VLP vaccine was treated with UV-C or formalin to study whether stability a…

0301 basic medicinePharmacologybiologyChemistryvirusesImmunogenicity030106 microbiologyCellIndustrial scalevirus diseasesAseptic meningitisAntibody levelCoxsackievirusmedicine.diseasebiology.organism_classificationcomplex mixturesVirology3. Good health03 medical and health sciences030104 developmental biologyAntibody responsemedicine.anatomical_structureVirus-like particleVirologymedicineAntiviral Research
researchProduct

Enterovirus-induced non-acidic entry pathway and its relation to the epidermal growth factor receptor pathway

2014

coxsackievirus A9echovirus 1enteroviruksetviruksetEGFRendocytosisendosomitECHO-viruksetepidermaalisen kasvutekijän reseptoriepidermal growth factor receptorendosytoosimultivesicular bodysolubiologia
researchProduct

Odpamiętywanie przeszłości. Historia Białorusi w powieściach Uładzimira Karatkieviča

2020

The main goal of U. Karatkevič’s work has always been an attempt to revive and strengthen the sense of national identity of Belarusians. There was no writer in Belarusian literature who devoted all his work to the history of his own nation. In his works, the writer described the ups and downs of Belarusians, showed their attempts to achieve independence, shaped in his reader the basis of Belarusian national identity. In the 1950s and 1960s in the USSR, it was not easy to promote the true history of Belarus, beauty Belarusian language and Belarusian national identity. Karatkevič was often stigmatized and punished for his actions in this field. The article presents the influence of the writer…

identity of Belarusianstożsamość Białorusinówliteratura białoruskaBelarusBiałoruśBelarusian literatureKaratkievič
researchProduct